CUV 0.57% $14.17 clinuvel pharmaceuticals limited

fda meeting then rise, page-29

  1. 680 Posts.
    This stock will see 40c before 80c
    Anyone with half a brain knows that.
    They do not have enough momey to
    market the product.
    Share dilution is inevitable.
    Even if this product gets to the shelves ( and that's a big IF ) .
    The market is limited .
    We don't even know if its affordable.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.